Skip to content
Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

DRUG DEALER TRIO MAKE FORBES’ “RICHEST” LIST

Now The New York Times reports, on 7 October, on the windfall experienced by three individuals associated with Moderna, the Cambridge, Massachusetts firm that markets one and only one product, its COVID-19 vaccine. That windfall has, for the first time, put those individuals’ names on the Forbes Magazine list of the 400 richest persons in the U.S.
The three are Noubar Afeyan, Moderna’s chairman and co-founder, Robert Langer, a Massachusetts Institute of Technology professor and Moderna co-founder, and Timothy Springer, a Harvard Medical School professor and an early investor in Moderna. Each now has a net worth of over $3.5 billion.
When Forbes published, on 5 October, the latest edition of its annual list, it noted that the collected wealth of the 400 richest persons increased by 40 percent over the previous year. The COVID War has certainly done nothing to change the old adage about the rich getting richer; see “$4 TRILLION FOR BILLIONAIRES AS MIDDLE CLASS SHRINKS” (23 Mar 2021).
Their new status shouldn’t surprise the three from Moderna; they were certainly aware, as were their investors, that they were sitting on a potential gold mine, as did Trends Journal, which reported—in “DRUG LORD: COVID IS ‘FOREVER’” (19 Jan 2021)—on Moderna’s CEO, Stephane Bancel, cashing in Moderna stock worth some $40 million.
TREND FORECAST: The COVID War has been a financial windfall for many, and especially for those associated with providing the vaccines that the world sees as the main line of defense against the virus; see, for example:

Nor should any Trends Journal reader be surprised at reading this article and experiencing a sense of déjà vu, having read “VAX MINTS NEW BILLIONAIRES” (25 May 2021).
Moreover, in our economic section of the Trends Journal, weekly we have been reporting on the record breaking merger and acquisition activity and “Bigs Getting Bigger.”
Indeed, supporting our Trend Forecasts of the rich getting richer while We the People working on the Plantation of Slavelandia keep getting poorer, as reported by Zero Hedge last week, “THE US IS OFFICIALLY A BANANA REPUBLIC: THE TOP 1% NOW OWN MORE WEALTH THAN THE ENTIRE MIDDLE CLASS.” 

Comments are closed.